Abstract
The objective of this study was to determine the concordance between the Iranian Behçet’s disease dynamic activity measure (IBDDAM) or the Behçet’s disease current activity form (BDCAF) and expert physician global assessment (PGA) in the evaluation of disease activity changes in Behçet’s disease (BD). In a prospective study, 117 consecutive patients with BD were evaluated in their two consecutive follow-up visits by IBDDAM and BDCAF. The change in disease activity was determined (increased, unchanged or decreased) according to the PGA. We used receiver operating characteristic (ROC) curve to determine an appropriate cutoff point for disease activity change. Comparison was made by Stata and kappa analysis. Comparing the area under the ROC curve showed a significant difference between IBDDAM and BDCAF (p < 0.03). The difference was more significant between nonocular IBDDAM and BDCAF (p < 0.002). Better concordance was also observed for IBDDAM (nonocular and total) with PGA than BDCAF. The difference was not significant for ocular IBDDAM. The best cutoff point for nonocular IBDDAM was 0.45, for ocular IBDDAM was 3.5, and for BDCAF was 1 point. IBDDAM was the preferred method for the evaluation of disease activity change in patients with BD (without ocular involvement) considering a change of at least 0.45.
Similar content being viewed by others
References
Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341:1284–91.
Davatchi F. Behçet’s disease. In: Howe HS, Feng PH, editors. Textbook of clinical rheumatology. Singapore: National Arthritis Foundation; 1998. p. 298–315.
Chamberlain M, Noble B, Behçet’s U.K. Study Group. Disease activity in Behçet’s disease. In: O’Duffy J, Kokmen E, editors. Behçet’s disease. Basic and clinical aspects. New York: Marcel Dekker; 1991. p. 299–302.
Jamshidi A, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C, et al. The accuracy of IBDDAM (Iran Behçet’s disease dynamic activity measure) in the treatment evaluation of Behçet’s disease. APLAR J Rheumatol. 2001;4:161–3.
Hamuryudan V, Fresko I, Direskeneli H, Tenant M, Yurdakul S, Akoglu T, et al. Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology. 1999;38:734–6.
Muftuoglu A, Yazici H, Yurdakul S, Tuzun Y, Pazarli H, Gungen G, et al. Behçet’s disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol. 1986;25:235–9.
Bhakta B, Brennan P, James T, Chamberlain M, Noble B, Silman A. Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology. 1999;38:728–33.
Lawton G, Bhakta B, Chamberlain M, Tennant A. The Behçet’s disease activity index. Rheumatology. 2004;43:73–8.
Baltaci M. A review on disease activity scores in Behçet’s disease. Arthritis Res Ther. 2003;5(Suppl 2):7.
Davatchi F, Akbarian M, Shahram F, Tebbi M, Chams C, Chams H. Iran Behçet’s disease dynamic activity measure. Abstracts of the XIIth European congress of rheumatology. Hungarian Rheumatol. 1991;32:134 (abstract FP10–100).
Bhakta B, Hamuryudan V, Brennan P, Chamberlain M, Barnes C, Silman A. Assessment of disease activity in Behçet’s disease. In: Wechsler B, Godeau P, editors. Excerpta medica international congress series, 1037, 611. Amsterdam: Elsevier Science; 1993. p. 235–40.
International Study Group for Behçet’s disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.
Chamberlain M, Bhakta B, Tennant A, Eyres S. Behçet’s disease: diagnosis and assessment of disease activity. In: Bang D, Lee E, Lee S, editors. Behçet’s disease. Seoul: Design Mecca; 2000. p. 105–9.
Dinc A, Erdem H. IBDDAM vs. Leeds scoring to measure disease activity in Behçet’s patients. In: 10th International conference on Behçet’s disease, June 2002, Berlin, Germany. Programme and abstracts: p. 59 (Abstract 010).
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shahram, F., Khabbazi, A., Nadji, A. et al. Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease. Mod Rheumatol 19, 536–541 (2009). https://doi.org/10.1007/s10165-009-0191-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-009-0191-z